Your browser doesn't support javascript.
loading
Predicting the environmental suitability for onchocerciasis in Africa as an aid to elimination planning.
Cromwell, Elizabeth A; Osborne, Joshua C P; Unnasch, Thomas R; Basáñez, Maria-Gloria; Gass, Katherine M; Barbre, Kira A; Hill, Elex; Johnson, Kimberly B; Donkers, Katie M; Shirude, Shreya; Schmidt, Chris A; Adekanmbi, Victor; Adetokunboh, Olatunji O; Afarideh, Mohsen; Ahmadpour, Ehsan; Ahmed, Muktar Beshir; Akalu, Temesgen Yihunie; Al-Aly, Ziyad; Alanezi, Fahad Mashhour; Alanzi, Turki M; Alipour, Vahid; Andrei, Catalina Liliana; Ansari, Fereshteh; Ansha, Mustafa Geleto; Anvari, Davood; Appiah, Seth Christopher Yaw; Arabloo, Jalal; Arnold, Benjamin F; Ausloos, Marcel; Ayanore, Martin Amogre; Baig, Atif Amin; Banach, Maciej; Barac, Aleksandra; Bärnighausen, Till Winfried; Bayati, Mohsen; Bhattacharyya, Krittika; Bhutta, Zulfiqar A; Bibi, Sadia; Bijani, Ali; Bohlouli, Somayeh; Bohluli, Mahdi; Brady, Oliver J; Bragazzi, Nicola Luigi; Butt, Zahid A; Carvalho, Felix; Chatterjee, Souranshu; Chattu, Vijay Kumar; Chattu, Soosanna Kumary; Cormier, Natalie Maria; Dahlawi, Saad M A.
Afiliação
  • Cromwell EA; Institute for Health Metrics and Evaluation, University of Washington, Seattle, Washington, United States of America.
  • Osborne JCP; Department of Health Metrics Sciences, School of Medicine, University of Washington, Seattle, Washington, United States of America.
  • Unnasch TR; Institute for Health Metrics and Evaluation, University of Washington, Seattle, Washington, United States of America.
  • Basáñez MG; GlobalHealth Infectious Disease, University of South Florida, Tampa, Florida, United States of America.
  • Gass KM; London Centre for Neglected Tropical Disease Research (LCNTDR), Imperial College London, London, United Kingdom.
  • Barbre KA; MRC Centre for Global Infectious Disease Analysis (MRC-GIDA), Imperial College London, London, United Kingdom.
  • Hill E; Neglected Tropical Diseases Support Center, Task Force for Global Health, Decatur, Georgia, United States of America.
  • Johnson KB; Neglected Tropical Diseases Support Center, Task Force for Global Health, Decatur, Georgia, United States of America.
  • Donkers KM; Institute for Health Metrics and Evaluation, University of Washington, Seattle, Washington, United States of America.
  • Shirude S; Institute for Health Metrics and Evaluation, University of Washington, Seattle, Washington, United States of America.
  • Schmidt CA; Institute for Health Metrics and Evaluation, University of Washington, Seattle, Washington, United States of America.
  • Adekanmbi V; Institute for Health Metrics and Evaluation, University of Washington, Seattle, Washington, United States of America.
  • Adetokunboh OO; Institute for Health Metrics and Evaluation, University of Washington, Seattle, Washington, United States of America.
  • Afarideh M; Population Health Sciences, King's College London, London, England.
  • Ahmadpour E; Centre of Excellence for Epidemiological Modelling and Analysis, Stellenbosch University, Stellenbosch, South Africa.
  • Ahmed MB; Department of Global Health, Stellenbosch University, Cape Town, South Africa.
  • Akalu TY; Department of Dermatology, Mayo Clinic, Rochester, Minnesota, United States of America.
  • Al-Aly Z; Endocrinology and Metabolism Research Center, Tehran University of Medical Sciences, Tehran, Iran.
  • Alanezi FM; Infectious and Tropical Diseases Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
  • Alanzi TM; Department of Epidemiology, Jimma University, Jimma, Ethiopia.
  • Alipour V; Australian Center for Precision Health, University of South Australia, Adelaide, South Australia, Australia.
  • Andrei CL; Department of Epidemiology and Biostatistics, University of Gondar, Gondar, Ethiopia.
  • Ansari F; John T. Milliken Department of Internal Medicine, Washington University in St. Louis, St. Louis, Montana, United States of America.
  • Ansha MG; Clinical Epidemiology Center, Department of Veterans Affairs, St Louis, Montana, United States of America.
  • Anvari D; Imam Abdulrahman Bin Faisal University, Dammam, Saudi Arabia.
  • Appiah SCY; Health Information Management and Technology Department, Imam Abdulrahman Bin Faisal University, Dammam, Saudi Arabia.
  • Arabloo J; Health Management and Economics Research Center, Iran University of Medical Sciences, Tehran, Iran.
  • Arnold BF; Health Economics Department, Iran University of Medical Sciences, Tehran, Iran.
  • Ausloos M; Cardiology Department, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania.
  • Ayanore MA; Research Center for Evidence Based Medicine, Tabriz University of Medical Sciences, Tabriz, Iran.
  • Baig AA; Razi Vaccine and Serum Research Institute, Agricultural Research, Education, and Extension Organization (AREEO), Tehran, Iran.
  • Banach M; Department of Public Health, Debre Berhan University, Debre Berhan, Ethiopia.
  • Barac A; Department of Parasitology, Mazandaran University of Medical Sciences, Sari, Iran.
  • Bärnighausen TW; Department of Parasitology, Iranshahr University of Medical Sciences, Iranshahr, Iran.
  • Bayati M; Department of Sociology and Social Work, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana.
  • Bhattacharyya K; Center for International Health, Ludwig Maximilians University, Munich, Germany.
  • Bhutta ZA; Health Management and Economics Research Center, Iran University of Medical Sciences, Tehran, Iran.
  • Bibi S; Department of Ophthalmology, University of California San Francisco, San Francisco, California, United States of America.
  • Bijani A; School of Business, University of Leicester, Leicester, United Kingdom.
  • Bohlouli S; Department of Statistics and Econometrics, Bucharest University of Economic Studies, Bucharest, Romania.
  • Bohluli M; Department of Health Policy Planning and Management, University of Health and Allied Sciences, Ho, Ghana.
  • Brady OJ; Unit of Biochemistry, Sultan Zainal Abidin University (Universiti Sultan Zainal Abidin), Kuala Terengganu, Malaysia.
  • Bragazzi NL; Department of Hypertension, Medical University of Lodz, Lodz, Poland.
  • Butt ZA; Polish Mothers' Memorial Hospital Research Institute, Lodz, Poland.
  • Carvalho F; Clinic for Infectious and Tropical Diseases, Clinical Center of Serbia, Belgrade, Serbia.
  • Chatterjee S; Faculty of Medicine, University of Belgrade, Belgrade, Serbia.
  • Chattu VK; Heidelberg Institute of Global Health (HIGH), Heidelberg University, Heidelberg, Germany.
  • Chattu SK; T.H. Chan School of Public Health, Harvard University, Boston, Massachusetts, United States of America.
  • Cormier NM; Health Human Resources Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
  • Dahlawi SMA; Department of Statistical and Computational Genomics, National Institute of Biomedical Genomics, Kalyani, India.
PLoS Negl Trop Dis ; 15(7): e0008824, 2021 07.
Article em En | MEDLINE | ID: mdl-34319976
ABSTRACT
Recent evidence suggests that, in some foci, elimination of onchocerciasis from Africa may be feasible with mass drug administration (MDA) of ivermectin. To achieve continental elimination of transmission, mapping surveys will need to be conducted across all implementation units (IUs) for which endemicity status is currently unknown. Using boosted regression tree models with optimised hyperparameter selection, we estimated environmental suitability for onchocerciasis at the 5 × 5-km resolution across Africa. In order to classify IUs that include locations that are environmentally suitable, we used receiver operating characteristic (ROC) analysis to identify an optimal threshold for suitability concordant with locations where onchocerciasis has been previously detected. This threshold value was then used to classify IUs (more suitable or less suitable) based on the location within the IU with the largest mean prediction. Mean estimates of environmental suitability suggest large areas across West and Central Africa, as well as focal areas of East Africa, are suitable for onchocerciasis transmission, consistent with the presence of current control and elimination of transmission efforts. The ROC analysis identified a mean environmental suitability index of 0·71 as a threshold to classify based on the location with the largest mean prediction within the IU. Of the IUs considered for mapping surveys, 50·2% exceed this threshold for suitability in at least one 5 × 5-km location. The formidable scale of data collection required to map onchocerciasis endemicity across the African continent presents an opportunity to use spatial data to identify areas likely to be suitable for onchocerciasis transmission. National onchocerciasis elimination programmes may wish to consider prioritising these IUs for mapping surveys as human resources, laboratory capacity, and programmatic schedules may constrain survey implementation, and possibly delaying MDA initiation in areas that would ultimately qualify.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Oncocercose / Erradicação de Doenças Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans País como assunto: Africa Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Oncocercose / Erradicação de Doenças Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans País como assunto: Africa Idioma: En Ano de publicação: 2021 Tipo de documento: Article